Aging at the cellular level is a complex process resulting from accumulation of various
damages leading to functional impairment and a reduced quality of life at the level of the …

Given the observed efficacy of culture‐expanded multipotential stromal cells, also termed
mesenchymal stem cells (MSCs), in the treatment of graft‐versus host and cardiac disease, it …

Purpose Bone marrow concentrate (BMC) and platelet-rich plasma (PRP) are used
extensively in regenerative medicine. The aim of this study was to determine differences in …

Several investigators have cultivated marrow stromal cells and have identified a population
of mesenchymal stem cells (MSCs). These cells expand extensively in vitro and exhibit …

Objective Surgically induced periosteal membrane holds great potential for the treatment of
large bone defects representing a simple alternative to combinations of exogenous stem …

Mesenchymal stem cells (MSC) are capable of differentiating into cells of multiple cell
lineages and have potent paracrine effects. Due to their easy preparation and low …

Mesenchymal stromal (stem) cells (MSCs) continue to be a strong area of focus for
academic-and industry-based researchers who share the goal of expanding their …

Bone marrow-derived mesenchymal stem/stromal cells (MSCs) have demonstrated success
in the clinical treatment of hematopoietic pathologies and cardiovascular disease and are …

Introduction Repair of large bone defects remains a significant clinical challenge. Bone
marrow stromal cells (BMSCs), a subset of which is known as bone marrow-derived …

The mesenchymal stromal cell (MSC) field continues to rapidly progress with a number of
clinical trials initiated and completed, with some reported successes in multiple clinical …